Pathologic Considerations and Standardization in Mesothelioma Clinical Trials-Reference-Cited by-同舟云学术

Pathologic Considerations and Standardization in Mesothelioma Clinical Trials

Published:2019-10 Issue:10 Volume:14 Page:1704-1717
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Tsao Ming-Sound,Carbone Michele,Galateau-Salle Francoise,Moreira Andre L.,Nicholson Andrew G.,Roden Anja C.,Adjei Alex A.,Aubry Marie-Christine,Fennell Dean A.,Gomez Daniel,Harpole David,Hesdorffer Mary,Hirsch Fred R.,Liu Geoffrey,Malik Shakun,Nowak Anna,Peikert Tobias,Salgia Ravi,Szlosarek Peter,Taioli Emanuela,Yang Haining,Tsao Anne,Mansfield Aaron S.

Funder

Foundation for the National Institutes of Health

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference129 articles.

1. Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline;Kindler;J Clin Oncol,2018

2. Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database;Meyerhoff;J Surg Res,2015

3. Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trials;Mansfield;Lung Cancer,2014

4. Amount of epithelioid differentiation is a predictor of survival in malignant pleural mesothelioma;Vigneswaran;Ann Thorac Surg,2017

5. Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients;Sugarbaker;Ann Surg,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DHEA-S, Androstenedione, 17-β-estradiol signature as novel biomarkers for early prediction of risk of malignant pleural mesothelioma linked to asbestos-exposure: A preliminary investigation;Biomedicine & Pharmacotherapy;2024-06

2. Did the Ban on Asbestos Reduce the Incidence of Mesothelioma?;Journal of Thoracic Oncology;2023-06

3. Immunotherapy approaches for malignant pleural mesothelioma;Nature Reviews Clinical Oncology;2022-07-01

4. DNA Methylation Profiling Discriminates between Malignant Pleural Mesothelioma and Neoplastic or Reactive Histologic Mimics;The Journal of Molecular Diagnostics;2021-07

5. Potential role of serum mesothelin in predicting survival of patients with malignant pleural mesothelioma;Oncology Letters;2020-12-18